Corrigendum to “Restoring lysosomal proteostasis reverses steatohepatitis and fibrosis in experimental MASH” [Pharmacol. Res. 232 (2026) 108427]
Pharmacological Research · 2026-11 · 233 · 108480
DOI: 10.1016/j.phrs.2026.108480 ↗Kurz gefasst
Korrektur in der Zeitschrift Pharmacological Research, 2026-11. Verfasst von Dylan Mastrippolito und 7 weiteren Autor:innen. Beteiligte Einrichtung: CNRS UMR7242, Biotechnology and Cell Signaling, University of Strasbourg/Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, Franc…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Université de Strasbourg, Agence Nationale de la Recherche.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- CNRS UMR7242, Biotechnology and Cell Signaling, University of Strasbourg/Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France.
- CNRS UMR7242, Biotechnology and Cell Signaling, University of Strasbourg/Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France; CNRS UMR7369 Matrice Extracellulaire et Dynamique Cellulaire, Unive…
- CNRS UPR4301, Centre de Biophysique Moléculaire, Orléans, France.
- CNRS UMR7369 Matrice Extracellulaire et Dynamique Cellulaire, University of Reims Champagne-Ardenne, Reims, France.
- CNRS UMR7242, Biotechnology and Cell Signaling, University of Strasbourg/Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France; University of Strasbourg Institute for Advanced Study (USIAS), Stra…
Förderung
- European Regional Development Fund
- Université de Strasbourg
- Agence Nationale de la Recherche
Zitieren
APA
Mastrippolito, D., Gur, L., Lasalo, M., El Kaakour, L., Verdot, C., Coste, F., Blaise, S., & Muller, S. (2026). Corrigendum to “Restoring lysosomal proteostasis reverses steatohepatitis and fibrosis in experimental MASH” [Pharmacol. Res. 232 (2026) 108427]. Pharmacological Research, 233, 108480. https://doi.org/10.1016/j.phrs.2026.108480
Vancouver
Mastrippolito D, Gur L, Lasalo M, El Kaakour L, Verdot C, Coste F, et al. Corrigendum to “Restoring lysosomal proteostasis reverses steatohepatitis and fibrosis in experimental MASH” [Pharmacol. Res. 232 (2026) 108427]. Pharmacological Research. 2026;233:108480. doi:10.1016/j.phrs.2026.108480
BibTeX
@article{Mastrippolito2026,
author = {Mastrippolito, Dylan and Gur, Lauriane and Lasalo, Malia and El Kaakour, Lara and Verdot, Cindy and Coste, Franck and Blaise, Sébastien and Muller, Sylviane},
title = {Corrigendum to “Restoring lysosomal proteostasis reverses steatohepatitis and fibrosis in experimental MASH” [Pharmacol. Res. 232 (2026) 108427]},
journal = {Pharmacological Research},
year = {2026},
volume = {233},
pages = {108480},
doi = {10.1016/j.phrs.2026.108480}
}
EUVIMED